pharmaphorum | News & views on pharma and biotech’s evolving …
pharmaphorum is an online publication seeking to educate, inform, engage, & connect pharmaceutical industry leaders to thrive in healthcare’s evolving future.
News | Timely industry updates for pharma and biotech leaders
4 days ago · pharmaphorum’s news coverage updates daily with the latest pharma and biotech stories, from funding and M&A to regulatory approvals and policy shifts.
Two more biotechs join IPO waiting list | pharmaphorum
2 days ago · Odyssey Therapeutics and Sionna Therapeutics have filed to carry out initial public offerings (IPOs) on the Nasdaq, taking the number in the newly-filed queue to four since the …
Life Sciences Industry Report 2025 | pharmaphorum
Jan 9, 2025 · In pharmaphorum’s inaugural Life Sciences Industry Report 2025, delve into the trends that propelled the pharmaceutical industry along in 2024.
About pharmaphorum
4 days ago · pharmaphorum.com is a leading online destination for healthcare and pharmaceutical industry news, insight, and debate – as is its associated digital magazine Deep …
pharmaphorum - The Deep Dive Digital Magazine has fresh …
Feb 28, 2024 · Digital Health 2023. 29-11-2023 Deep Dive – Digital Health 2023 features interviews, analysis, and commentary from pharmaphorum, Lumanity, AXON, Viseven, …
Takeda spinout Phathom claims its first FDA approvals
5 days ago · Three years after it was formed as a spinout of Japanese drugmaker Takeda, Phathom Pharmaceuticals has racked up its first FDA approvals, and claimed a sizeable $260 …
China in the fast lane - pharmaphorum
Provincial reimbursed drugs list (PRDL): After receiving marketing authorisation, manufacturers can enter negotiations with provinces directly and be listed on their PRDL. However, the …
Biopharma’s AI rally: Readiness not hype in 2025
Jan 16, 2025 · Discover how the biopharmaceutical industry is embracing AI in a practical and effective way by focusing on readiness and implementation strategies for 2025.
Views & Analysis | Perspectives on pharma industry issues
5 days ago · Diverse and engaging perspectives on pharma developments and debates from pharmaphorum editors, industry insiders, and contributing experts.